Here’s a look at how Covid-19 is spreading in communities across the United States

A crematorium in Meissen, Germany last week.
A crematorium in Meissen, Germany last week. (Robert Michael / picture alliance / Getty Images)

Global cases of Covid-19 rose 11% during the week of December 20-26 compared to the previous week, while the death toll remained the same, according to the weekly epidemiological update from the World Health Organization (WHO), published on Tuesday.

This growth in cases follows “a gradual increase since October,” says the WHO, with just under 5 million reported cases. Overall, per. December 26 have been reported over 278 million cases.

North and South America reported the largest increase in new cases of 39%, followed by the African region with an increase of 7%. The regions of Europe, the eastern Mediterranean and the western Pacific all reported similar case numbers as the week before. The region of Southeast Asia reported a decrease of 12% compared to the week before.

The United States reported the highest number of new cases, followed by Britain, France, Italy and Germany.

The number of deaths, over 44,000 in the past week, corresponded to the number of deaths the week before. There have been just over 5.4 million deaths reported globally per year. December 26th.

The highest number of new deaths was reported in the African region, an increase of 72% from the week before. It is followed by the region of Southeast Asia with an increase of 9% and North and South America with 7%. The western Pacific region had a number similar to the week before. There was a 12% decrease in deaths in the European region and a 7% decrease in deaths in the Eastern Mediterranean region.

Looking at the Omicron variant, the WHO says that “the overall risk associated with the new concern variant Omicron remains very high.”

It also notes consistent evidence showing the growth advantage of Omicron over Delta, the two to three day doubling time and “rapid increases in the incidence of cases seen in a number of countries, including those where the variant has become the dominant SARS-CoV -2 variant, such as the United Kingdom and the United States. “

The WHO notes that there has been a decline in cases in South Africa where the variant was first identified.

It also says that although early data suggest a reduced risk of hospitalization, more data are needed to understand the clinical markers of severity and how severity may be affected by previous infection and vaccination.

For tests, the WHO says preliminary data suggest that PCR and antigen-based rapid tests do not appear to be affected by Omicron. Treatments state that corticosteroids and interleukin 6 receptor blockers are expected to remain effective, however, monoclonal antibodies may be less able to neutralize Omicron.


Leave a Comment